UnitedHealth (UNH) Director Granted 270 Deferred Stock Units
UnitedHealth Group (UNH) director Valerie C. Montgomery Rice, M.D. was granted 270 deferred stock units on 10/01/2025 as part of regular quarterly director compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
UnitedHealth Group (UNH) director Valerie C. Montgomery Rice, M.D. was granted 270 deferred stock units on 10/01/2025 as part of regular quarterly director compensation. The units are immediately vested but must be held until she leaves the board. After the grant, her reported beneficial ownership of common stock is 6,897 shares, held directly. The Form 4 was signed by an attorney-in-fact on 10/03/2025.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 270 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction did Valerie C. Montgomery Rice, M.D. report on Form 4 for UNH?
Are the deferred stock units vested or restricted according to the filing?
Was the Form 4 filed jointly or by one reporting person for UNH?
Who signed the Form 4 for Valerie C. Montgomery Rice, M.D.?
AI-generated analysis. How Rhea-AI works. Not financial advice.